DocDollars

Dermavant Sciences, Inc.

CA · United States · Reporting entity ID 100001156901

Total reported 2019–2025
$25.6M
#275 of 2,960 reporting companies — 0% of all reported industry payments
$13.8M in general payments across 135,855 records, plus $11.8M in research funding across 31,293 records.

How it breaks down

General payments $13,842,375
Research funding $11,761,524

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Dermavant Sciences, Inc. reported $25.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #275 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 135,855 general payment records and 31,293 research records were filed.

Common questions about Dermavant Sciences, Inc.

How much has Dermavant Sciences, Inc. paid US doctors?

Dermavant Sciences, Inc. reported $25,603,900 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,842,375 in general payments, $11,761,524 in research funding.

How does Dermavant Sciences, Inc. rank among drug and device companies?

It ranks #275 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Dermavant Sciences, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.